Business Description
Xuanzhu Biopharmaceutical, founded in 2008 and based in Beijing, China, is a drug development company focused on creating and bringing to market both small-molecule and biological medicines. The company's pipeline covers a broad range of serious conditions, with a particular emphasis on cancer treatments targeting breast cancer, lung cancer, and other tumors, as well as therapies for digestive disorders. Several of its drug candidates are in active clinical trials, and a number are designed to work through mechanisms not yet explored by existing approved medicines. Originally part of Sihuan Pharmaceutical Holdings Group, Xuanzhu now operates as an independent company.
